drugset / Trial / NCT02184078

Study to Determine the Effects of Nevirapine (VIRAMUNE®) on the Steady State Pharmacokinetics of Rifabutin (MYCOBUTIN®) in HIV+ Patients

NCT02184078

Phase 4 Completed 19 enrolled Boehringer Ingelheim
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Study to determine the effects of nevirapine on the steady state pharmacokinetics of rifabutin and to assess the steady state pharmacokinetics of nevirapine when given in combination with rifabutin

Timeline

Start
1998-10
Primary completion
1998-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Nevirapine Small molecule
Subject Rifabutin Small molecule